变种和疫苗
Nathan D Grubaugh1, Sarah Cobey2
1Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06510, USA; Department of Ecology and Evolutionary Biology, Yale University, New Haven, CT 06510, USA.
Cell
|December 23, 2021
概括
在疫情初期,即使没有免疫逃生,也强烈选择了更易传播的SARS-CoV-2变种. 人口免疫力上升使未来病毒演变和变种出现的预测变得复杂.
科学领域:
- 病毒学
- 流行病学
- 进化生物学
背景情况:
- 在早期的SARS-CoV-2大流行中,新变种迅速出现.
- 了解变种选择的驱动因素对于公共健康至关重要.
- 免疫逃生是已知的因素,但其他传染性优势也可能起作用.
研究的目的:
- 在疫情初期调查SARS-CoV-2变种的选择压力.
- 确定单独增加的传染性,没有免疫逃生,是否可以驱动变种选择.
- 模拟增加人群免疫力对未来变种动态的影响.
主要方法:
- 病毒演变的计算模型.
- 对早期SARS-CoV-2大流行病的流行病学数据的分析.
- 在不同的免疫场景下模拟变体选择.
主要成果:
- 免疫逃生独立于增加的传染性是早期变种选择的重要因素.
- 这种机制解释了之前观察到的SARS-CoV-2变种的动态.
- 随着群体免疫力增长,预测新兴变种的特征变得更加具有挑战性.
结论:
- 传染性是SARS-CoV-2变种选择的关键驱动因素,特别是在免疫学上天真的人群中.
- 未来的流行病准备需要考虑传播能力和人口免疫力的模型.
- 预测病毒演变的轨迹需要动态建模方法.
相关概念视频
Vaccinations
45.8K
Overview
45.8K
Cancer Vaccines
554
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
554
Microorganisms in Medicine and Therapeutics
461
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
461
Viral Mutations
34.6K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
34.6K
Viral Recombination
23.9K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
23.9K
Cross-reactivity
31.7K
Overview
31.7K


